HIV-associated Isospora belli infection: Incidence and risk factors in the French Hospital Database on HIV

HIV Medicine

Volumn 8, Issue 2, 2007, Pages 124-130

  Guiguet, M ^a,b   Furco, A ^c   Tattevin, P ^d,e   Costagliola, D ^a,b,e   Molina, J M ^c   Billaud, E ^e   Boue, F ^e   Duval, X ^e   Duvivier, C ^e   Enel, P ^e   Fournier, S ^e   Gasnault, J ^e   Gaud, C ^e   Gilquin, J ^e   Grabar, S ^e   Khuong, M A ^e   Lang, J M ^e   Mary Krause, M ^e   Matheron, S ^e   Meyohas, M C ^e   Pialoux, G ^e   Poizot Martin, I ^e   Pradier, C ^e   Rouveix, E ^e   Salmon Ceron, D ^e   Sobel, A ^e   Tissot Dupont, H ^e   Yasdanpanah, Y ^e   more..

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e NONE

Author keywords

HIV; Intestinal pathogens; Isospora belli; Opportunistic infection; Protozoan parasite

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; PROTEINASE INHIBITOR; PYRIMETHAMINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SULFADIAZINE;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC DIARRHEA; COCCIDIOSIS; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FECES ANALYSIS; FEMALE; FOLLOW UP; FRANCE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INFORMATION PROCESSING; ISOSPORA BELLI; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; RACE DIFFERENCE; RISK FACTOR; RISK REDUCTION; SEXUAL TRANSMISSION; VIRUS TRANSMISSION; WEIGHT REDUCTION;

ADULT; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; INTESTINAL DISEASES, PARASITIC; ISOSPORIASIS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33847791319     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2007.00441.x     Document Type: Article

References (18)

1. Hung C, Chang S. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J Antimicrob Chemother 2004; 54: 849-853.
2. Miao Y, Awad-El-Kariem F, Franzen C et al. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25: 124-129.
3. Le Moing V, Bissuel F, Costagliola D et al. Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors. AIDS 1998; 12: 1395-1397.
4. Moore R, Chaisson R. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999; 13: 1933-1942.
5. Ives N, Gazzard B, Easterbrook P. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect Dis 2001; 42: 134-139.
6. Kartalija M, Sande M. Diarrhea and AIDS in the era of highly active antiretroviral therapy. Clin Infect Dis 1999; 28: 701-707.
7. Okhuysen P. Traveler's diarrhea due to intestinal protozoa. Clin Infect Dis 2001; 33: 110-114.
8. Verdier R, Fitzgerald D, Johnson W, Pape J. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med 2000; 132: 885-888.
9. Cotte L, Rabodonirina M, Piens M, Perreard M, Mojon M, Trepo C. Prevalence of intestinal protozoans in French patients infected with HIV. J Acquir Immune Defic Syndr 1993; 6: 1024-1029.
10. Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet 1996; 348: 379-383.
11. Sorvillo F, Lieb L, Seidel J, Kerndt P, Turner J, Ash L. Epidemiology of isosporiasis among persons with acquired immunodeficiency syndrome in Los Angeles County. Am J Trop Med Hyg 1995; 53: 656-659.
12. Holmes C, Losina E, Walensky R, Yazdanpanah Y, Freedberg K. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis 2003; 36: 652-662.
13. Silva C, Ferreira M, Borges A, Costa-Cruz J. Intestinal parasitic infections in HIV/AIDS patients: Experience at a teaching hospital in central Brazil. Scand J Infect Dis 2005; 37: 211-215.
14. Certad G, Arenas-Pinto A, Pocaterra L et al. Isosporiasis in Venezuelan adults infected with human immunodeficiency virus: Clinical characterization. Am J Trop Med Hyg 2003; 69: 217-222.
15. Grabar S, Le Moing V, Goujard C et al. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med 2000; 133: 401-410.
16. Lanoy E, Mary-Krause M, Tattevin P et al. Frequency, determinants and consequences of delayed access to care for HIV patients in France. Antivir Ther 2007; 12: 89-96.
17. Anglaret X, Chêne G, Attia A et al. Early chemoprophylaxis with trimetoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: A randomised trial. Lancet 1999; 353: 1463-1468.
18. Dworkin M, Williamson J, Jones J, Kaplan J and the Adult Adolescent Spectrum of HIV Disease Project. Prophylaxis with trimetropim-sulfamethoxazole for human immunodeficiency virus-infected patients: Impact on risk for infectious diseases. Clin Infect Dis 2001; 33: 393-398.